FBA reveals guanylate kinase as a potential target for antiviral therapies against SARS-CoV-2

Bioinformatics

Alina Renz, Lina Widerspick, Andreas Dräger, Alina Renz, Lina Widerspick, Andreas Dräger

• DOI: 10.1093/bioinformatics/btaa813
• PMID: 33381848
• PMCID: PMC7773487